Identification and characterization of a ouabain-like compound from human plasma.
The plasma membrane sodium-potassium pumps that regulate intracellular sodium in most animal cells have specific, high-affinity receptors for the digitalis glycosides and their aglycones. This has fostered speculation that there is an endogenous ligand. We have purified and structurally identified by mass spectroscopy an endogenous substance from human plasma that binds with high affinity to this receptor and that is indistinguishable from the cardenolide ouabain. This human ouabain-like compound (OLC) displaces [3H]ouabain from its receptor, inhibits Na,K-ATPase and ouabain-sensitive 86Rb+ uptake, and has cardiotonic actions quantitatively similar to commercial ouabain. Immunoreactive OLC was detected in the plasma of many mammals, and high concentrations were found in the adrenals. The circulating OLC may modulate intracellular Na+ and affect numerous Na+ gradient-dependent processes including intracellular Ca2+ and pH homeostasis in many tissues. Furthermore, altered circulating levels of OLC may be associated with the pathogenesis of certain forms of hypertension.
Hamlyn
J M
JM
Department of Physiology, University of Maryland School of Medicine, Baltimore 21201.
Blaustein
M P
MP
Bova
S
S
DuCharme
D W
DW
Harris
D W
DW
Mandel
F
F
Mathews
W R
WR
Ludens
J H
JH
D000311:Adrenal Glands / Q000737:chemistry / Q000378:metabolism; D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D004285:Dogs; D004912:Erythrocytes / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000201:enzymology; D013058:Mass Spectrometry; D010042:Ouabain / Q000031:analogs & derivatives* / Q000097:blood / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D012413:Rubidium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism
D010042:Ouabain; D000254:Sodium-Potassium-Exchanging ATPase; D012413:Rubidium